Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Net Cash Flow (2016 - 2025)

Bio Key International's Net Cash Flow history spans 16 years, with the latest figure at -$161581.0 for Q3 2025.

  • For Q3 2025, Net Cash Flow fell 135.84% year-over-year to -$161581.0; the TTM value through Sep 2025 reached $272428.0, down 78.45%, while the annual FY2024 figure was -$100265.0, 95.75% up from the prior year.
  • Net Cash Flow for Q3 2025 was -$161581.0 at Bio Key International, up from -$917212.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $2.7 million in Q1 2025 and bottomed at -$3.5 million in Q1 2021.
  • The 5-year median for Net Cash Flow is -$828375.0 (2022), against an average of -$795378.5.
  • The largest annual shift saw Net Cash Flow crashed 5189.67% in 2024 before it skyrocketed 1014.41% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$1.8 million in 2021, then soared by 90.89% to -$167490.0 in 2022, then surged by 115.7% to $26291.0 in 2023, then plummeted by 5189.67% to -$1.3 million in 2024, then soared by 87.92% to -$161581.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Net Cash Flow are -$161581.0 (Q3 2025), -$917212.0 (Q2 2025), and $2.7 million (Q1 2025).